This inventor holds 1 USPTO granted patent. Top assignee: Abl Bio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hye Jin Chung: Innovator in Bispecific Antibodies
Introduction
Hye Jin Chung is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. Her innovative work has the potential to impact therapeutic strategies in various diseases.
Latest Patents
Hye Jin Chung holds a patent for "ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF." This patent represents her pioneering efforts in creating novel therapeutic agents that can target multiple pathways in disease treatment. She has achieved a remarkable milestone with 1 patent to her name.
Career Highlights
Currently, Hye Jin Chung is employed at Abl Bio Inc., a company known for its focus on innovative biopharmaceuticals. Her role at Abl Bio Inc. allows her to further her research and development efforts in the field of bispecific antibodies. Her work is instrumental in advancing the company's mission to create effective therapies.
Collaborations
Hye Jin Chung collaborates with talented colleagues, including Kyung Jin Park and Yang Soon Lee. These collaborations enhance the research environment and foster innovation within the team.
Conclusion
Hye Jin Chung is a prominent inventor whose work in bispecific antibodies is paving the way for new therapeutic approaches. Her contributions to the field are significant and reflect her dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile